| Stage | ARXS | % of rev | VSEC | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $564M | 100.00% | $449M | 100.00% | ARXS ×1.26 |
| Gross profit | $306M | 54.27% | $76M | 17.02% | ARXS +37.3pp |
| Operating income | $133M | 23.66% | $49M | 10.90% | ARXS +12.8pp |
| Pre-tax income | $120M | 21.23% | $39M | 8.74% | ARXS +12.5pp |
| Net income | $84M | 14.84% | $29M | 6.35% | ARXS +8.5pp |
| Stage | ARXS | VSEC | Gap · A − B |
|---|---|---|---|
| Revenue | $564M100.00% | $449M100.00% | ARXS ×1.26 |
| Gross profit | 54.27%$306M | 17.02%$76M | ARXS +37.3pp |
| Operating income | 23.66%$133M | 10.90%$49M | ARXS +12.8pp |
| Pre-tax income | 21.23%$120M | 8.74%$39M | ARXS +12.5pp |
| Net income |
| 14.84%$84M |
| 6.35%$29M |
| ARXS +8.5pp |
None
No disclosed counterparties: ARXS.